Cargando…
PFKFB3 Inhibition Sensitizes DNA Crosslinking Chemotherapies by Suppressing Fanconi Anemia Repair
SIMPLE SUMMARY: DNA-damaging chemotherapeutics, such as platinum drugs, are cornerstones in cancer treatment. The efficacy of such treatment is intimately linked to the DNA repair capacity of the cancer cells, as DNA damage above a tolerable threshold culminates in cell death. Cancer cells often hav...
Autores principales: | Ninou, Anna Huguet, Lehto, Jemina, Chioureas, Dimitrios, Stigsdotter, Hannah, Schelzig, Korbinian, Åkerlund, Emma, Gudoityte, Greta, Joneborg, Ulrika, Carlson, Joseph, Jonkers, Jos, Seashore-Ludlow, Brinton, Gustafsson, Nina Marie Susanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306909/ https://www.ncbi.nlm.nih.gov/pubmed/34298817 http://dx.doi.org/10.3390/cancers13143604 |
Ejemplares similares
-
Targeting CX3CR1 Suppresses the Fanconi Anemia DNA Repair Pathway and Synergizes with Platinum
por: Lehto, Jemina, et al.
Publicado: (2021) -
The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients
por: Åkerlund, Emma, et al.
Publicado: (2023) -
Targeting PFKFB3 radiosensitizes cancer cells and suppresses homologous recombination
por: Gustafsson, Nina M. S., et al.
Publicado: (2018) -
Fanconi-like crosslink repair in yeast
por: Daee, Danielle L, et al.
Publicado: (2012) -
Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention
por: Raivola, Juuli, et al.
Publicado: (2022)